# Commission Decision of 7 May 2002 on common technical specifications for in vitro-diagnostic medical devices (notified under document number C(2002) 1344) (Text with EEA relevance) (2002/364/EC), Division 3.3.6

Extent: E+W+S+N.I.

For investigation of potential carry-over, at least five runs with alternating high-positive and negative specimens shall be performed during robustness studies. The high positive samples shall comprise samples with naturally occurring high virus titres.

---
Source: https://www.legislation.gov.uk/eudn/2002/364/annex/division/3/division/3.3/division/3.3.6 (the official version)
Page: https://openlegislation.uk/eu-decision-2002-364/annex/division-3/division-3.3/division-3.3.6
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.